European Partnership on Rare Diseases (ERDERA) (Phase 2)
Ente erogante: Commissione Europea - Horizon Europe
Scadenza
15 settembre 2026
151 giorni rimanenti
Forma
Non specificata
Budget totale
Non specificato
Contributo max
Non specificato
Descrizione del bando
Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:The EU is reinforced as an internationally recognised driver of research and innovation in Rare Diseases (RD) and thereby substantially contributing to the achievement of the Sustainable Development Goals related to rare diseases.Research funders align, adopt and implement their RD research policies allowing for the optimal generation and translation of knowledge into meaningful health products and interventions responding to the needs of people living with a rare disease across Europe and globally.The RD research community at large benefit from and use an improved comprehensive knowledge framework and cross-border FAIR[1] data access and analysis, including rare diseases registries, by integrating the EU, national/regional data and information infrastructures to improve translational research.People living with a rare disease, including those from underrepresented communities, benefit from a more timely, equitable access to innovative, sustainable and high-quality healthcare including novel diagnosis and treatments, taking stock of highly integrated research and healthcare systems.Researchers, innovators -as well as people living with a rare disease and their advocates (as co-creators)- effectively constitute and operate into an integrated research and innovation ecosystem to deliver cost-effective diagnosis and treatments.Public and private actors, including civil society (e.g. Non-Governmental Organisations, charities), establish coordinated and efficient multi-stakeholder collaborations at EU and national (including regional) levels, allowing for more effective clinical research, for example aiming at improved su
Non capisci questo bando?
L'AI di Bandiora te lo spiega in modo semplice: requisiti, importi, scadenze e a chi è rivolto, tutto chiaro.
Registrati e fatti spiegare il bando dall'AIArea geografica
Tematiche
Requisiti dettagliati
Questo bando è rivolto a - tipologie di impresa in 3 settori ATECO nell'area eu.
Scopri con l'AI se questo bando è adatto alla tua azienda
Analisi automatica di compatibilità, requisiti e matching in tempo reale
Prova gratis 7 giorniQuesto bando fa per la tua azienda?
L'AI di Bandiora analizza la compatibilità con la tua azienda in tempo reale e ti assiste nella compilazione della candidatura, passo dopo passo.
Altri bandi che potrebbero interessarti
Support to test EIC innovations for public and private procurers
Commissione Europea
Scadenza: 17 aprile 2026
Accelerating the discovery and development of chemicals and innovative advanced materials through digitalisation and artificial intelligence (IA) (Innovative Advanced Materials for the EU partnership)
Commissione Europea - Horizon Europe
Scadenza: 21 aprile 2026
Improving availability of secondary raw materials through recycling (IA)
Commissione Europea - Horizon Europe
Scadenza: 21 aprile 2026
Monitoring of secondary raw materials (CSA)
Commissione Europea - Horizon Europe
Scadenza: 21 aprile 2026